Amarantus Biosciences or AMBS. Many professionals are saying this is the next Amgen. The company just received $20 million from Lincoln Park Capital and is set to release the worlds first Alzheimer's Blood Test named Lympro in the coming weeks. BD and Johnson & Johnson are possible partners for future development. GLTA and God Bless America.